Characterization of SHP2 phosphatase as a therapeutic target in myeloproliferative neoplasms using an ex vivo bioreactor platform

被引：0
|
作者：
Vokalova, L. [1 ,2 ,3 ]
Garcia-Garcia, A. [2 ,3 ]
Reinhardt, E. [2 ,3 ]
Genty, L. [2 ,3 ]
Plantier, E. [2 ,3 ]
Jungius, S. [1 ,2 ,3 ]
Brkic, S. [2 ,3 ]
Rovo, A. [1 ]
Angelillo-Scherrer, A. [4 ,5 ]
Ivan, M. [2 ,3 ]
Meyer, S. C. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Bern, Dept Biomed Res, Inselspital Bern, Bern, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Univ Hosp Basel, Dept Biomed, Basel, Switzerland
[4] Bern Univ Hosp, Dept Hematol, Inselspital, Bern, Switzerland
[5] Cent Hematol Lab, Bern, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P433
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [21] Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
    Lambert, Lester J.
    Romero, Celeste
    Sheffler, Douglas J.
    Celeridad, Maria
    Cosford, Nicholas D. P.
    Tautz, Lutz
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (161): : 1 - 14
  • [22] SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer
    Chen, Hao
    Libring, Sarah
    Ruddraraju, Kasi Viswanatharaju
    Miao, Jinmin
    Solorio, Luis
    Zhang, Zhong-Yin
    Wendt, Michael K.
    ONCOGENE, 2020, 39 (49) : 7166 - 7180
  • [23] Critical Role of SHP2 in the Initiation and Maintenance of Myeloproliferative Neoplasms Evoked By JAK2V617F
    Mohi, Golam
    Yan, Dongqing
    Jobe, Fatoumata
    Hutchison, Robert E.
    BLOOD, 2015, 126 (23)
  • [24] SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms
    Pandey, Garima
    Mazzacurati, Lucia
    Rowsell, Tegan M.
    Horvat, Nathan P.
    Amin, Narmin E.
    Zhang, Guolin
    Akuffo, Afua A.
    Colin-Leitzinger, Christelle M.
    Haura, Eric B.
    Kuykendall, Andrew T.
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    Reuther, Gary W.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (06) : 1040 - 1055
  • [25] Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells
    Raveendra-Panickar, Dhanya
    Finlay, Darren
    Layng, Fabiana Izidro
    Lambert, Lester J.
    Celeridad, Maria
    Zhao, Ming
    Barbosa, Karina
    De Backer, Laurent J. S.
    Kwong, Elizabeth
    Gosalia, Palak
    Rodiles, Socorro
    Holleran, John
    Ardecky, Robert
    Grotegut, Stefan
    Olson, Steven
    Hutchinson, John H.
    Pasquale, Elena B.
    Vuori, Kristiina
    Deshpande, Aniruddha J.
    Cosford, Nicholas D. P.
    Tautz, Lutz
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (01)
  • [26] Discovery of an allosteric small molecule inhibitor that can potently target SHP2 in vitro and in vivo
    Kim, M.
    Park, D.
    Kim, D.
    Lee, M.
    Jeon, D.
    Jang, S.
    Kim, J.
    Kim, E.
    Yoon, K. J.
    Lim, S. K.
    Lee, K.
    Choi, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S35 - S35
  • [27] Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention (vol 6, pg 1423, 2014)
    Butterworth, Sam
    Overduin, Michael
    Barr, Alastair J.
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (18) : 2132 - 2132
  • [28] SHP2 is a potential therapeutic target in scirrhous gastric carcinoma addicted to receptor tyrosine kinase signaling
    Yamaguchi, Hideki
    Miyazaki, Makoto
    Ohki, Rieko
    Yanagihara, Kazuyoshi
    Sakai, Ryuichi
    CANCER SCIENCE, 2023, 114 : 2063 - 2063
  • [29] Development of a Plate-Based Assay Platform to Monitor Cellular SHP2 Phosphatase Activity During Erythroid Differentiation
    Chu, Chi-Yuan
    Kuo, Chun-Chen
    Chen, Mei-Hsiao
    Chen, Kuan-Ju
    Lo, Lee-Chiang
    Lin, Jing-Jer
    JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2012, 59 (03) : 297 - 304
  • [30] Selective Inhibitors of the Protein Tyrosine Phosphatase SHP2 Block Cellular Motility and Growth of Cancer Cells in vitro and in vivo
    Grosskopf, Stefanie
    Eckert, Chris
    Arkona, Christoph
    Radetzki, Silke
    Boehm, Kerstin
    Heinemann, Udo
    Wolber, Gerhard
    von Kries, Jens-Peter
    Birchmeier, Walter
    Rademann, Joerg
    CHEMMEDCHEM, 2015, 10 (05) : 815 - 826
12345